Cognito Therapeutics is a pioneering company based in Cambridge, MA, that is dedicated to improving the lives of Alzheimer's patients through their innovative therapy. Their novel treatment aims to evoke specific brain wave activity, preserving brain structure, cognition, and function among individuals living with Alzheimer's disease.
With promising results from their Phase 2 study, Cognito Therapeutics has demonstrated significant slowing of disease progression and the preservation of cognition, daily function, and whole brain volume. Their non-invasive treatment is designed to fit into patients' lives, allowing them to receive therapy from the comfort of their own homes for one hour each day.
Generated from the website